In recent years, sci-tech innovation achievements have emerged in Guangzhou one after another, contributing to the high-quality development of strategic emerging industries. The Guangzhou Lab has been established; national large-scale scientific devices such as human cell lineage and cold seep ecosystem have been put into use; the added value of strategic emerging industries accounts for over 30% of the regional GDP; two industrial clusters, namely biomedicine and intelligent manufacturing equipment, have been recognized as national excellence; and the automobile productionranksfirst nationwide for five consecutive years.

"Biomanufacturing is becoming a new driving force for new productive forces." According to Professor Lin Ying at the School of Biology and Biological Engineering, South China University of Technology, Guangzhou owns a vast application market.

In recent years, Guangzhou has released a series of policy documents,includingMedium- and Long-term Development Plan of the Automobile Industry, Policy Measures to Promote the High-quality Development of the Biomedical Industry, and Implementation Opinions on Promoting High-quality Development of New Energy Storage Industry to promote the substantial improvement of these strategic emerging industries.

Lewwin Pharmaceutical Research Institute has built key technology platforms in cell and gene therapy drugs, new vaccines, ophthalmic drugs, pediatric drugs, and traditional Chinese medicine. It is the only research institute in Southern China that possesses GLP certification for ten categories of drugs issued by the NMPA.

In recent years, the business volume of Lewwin Pharmaceutical has grown at an average annual rate of over 50%, supporting the attainment of over 300 clinical approvals for Chinese medicine, chemical medicine, biological medicine, cell and gene therapy medicine by enterprises, universities, and research institutes, significantly contributing to the development of the biopharmaceutical industry in Guangzhou.

As the Chinese New Year celebration is over, the emergence of Sora has sparked the dawn of artificial intelligence. Dong Le, Vice Chairman and Executive Vice President of the Beijing Institute for General Artificial Intelligence, believes that the next breakthrough in the AI industry lies in building a general AI system with autonomous perceptual, cognitive, decision-making, learning, executive, and social collaboration capabilities. Compared to traditional technology of AI perception, general AI boasts lower customization cost, lower data computing power requirements, and better generalization performance.

"Intelligent manufacturing, vocational education, and resident healthcare are all advantageous industries in Guangzhou, all of which can be optimized when deeply integrated with AI," said Dong Le. He also cited the example of Guangzhou's automobile industry, stating that with the help of AI, intelligent management of the automobile industry chain and production parks can be reconstructed.

Guangzhou's ecosystem for industrial sci-tech innovation is constantly improving, bolstered by supportive policies and talent projects, contributing to six more academicians in Guangzhou and 48 national leading talents.

In addition, four new national-level intelligent manufacturing demonstration factories have opened; GAC Aion has been selected as the only global "lighthouse factory" for new energy vehicles; EHang's intelligent autonomous passenger aircraft has been awarded the world's first airworthiness certificate, and more. In 2023, Guangzhou has obtained 36,000 new invention patents, with a growth rate of 31.9%, and has been recognized as one of the first batch of national intellectual property protection demonstration zones and a national pilot region for innovative protection of trade secrets.

Source:Yangcheng Evening News

从科技端看广州新质生产力

近年来，广州科技创新成果竞相涌现，战略性新兴产业提质发展。广州实验室挂牌成立；人类细胞谱系、冷泉生态系统等国家大科学装置落地；战略性新兴产业增加值占地区生产总值的30%以上，生物医药、智能制造装备2个产业集群获评全国优秀，汽车产量连续5年全国第一。

“生物制造正在成为新质生产力的新增长点。”在华南理工大学生物科学与工程学院二级教授、博士林影看来，广州自带庞大的应用市场。

近年来，广州出台汽车产业中长期发展规划、促进生物医药产业高质量发展的若干政策措施、推动新型储能产业高质量发展的实施意见等系列政策文件，推动战略性新兴产业大发展大提升。

莱恩医药打造了细胞与基因治疗药物、新型疫苗、眼科药物、儿科药物、中药新药等特色关键技术平台，这是华南唯一一家拥有NMPA药物十项全项GLP认证资质的研究机构。

近年来，莱恩医药业务量增长达到年均50%以上，支撑企业、高校、科研院所获得中药、化药、生物药、细胞与基因治疗药物临床批件超过300个，大力支撑广州生物医药产业发展。

新年一过，Sora的问世彻底点燃了AI人工智能的火花。北京通用人工智能研究院副理事长、常务副院长董乐认为，人工智能行业的下一个爆发点在于构建实现具有自主的感知、认知、决策、学习、执行和社会协作能力的通用智能体。与传统感知AI技术相比，通用智能体具备更低定制成本、更低数据算力要求、更高泛化性能的特点。

“智能制造、职业教育、居民康养等都是广州的优势产业，可以和AI深度结合实现优化。”董乐还以广州的汽车产业举例称，借助AI可以重构汽车产业链制造和生产园区的智能化管理。

广州的产业科技创新生态正在不断完善。系列支持政策出台，人才工程落地，新增在穗院士6名、国家级领军人才48名。

此外，新增国家级智能制造示范工厂揭榜单位4家，广汽埃安入选全球唯一新能源汽车“灯塔工厂”，中科空天飞行科技产业化基地一期建成投产，亿航智能无人驾驶载人航空器获颁全球首张适航证……2023年，广州新增发明专利授权量3.6万件，增长31.9%，获评首批国家知识产权保护示范区、全国商业秘密保护创新试点地区。

文丨记者 杭莹 严锦程 通讯员 穗发宣
翻译丨洪婷